Johnson Investment Counsel’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$432K Hold
815
﹤0.01% 653
2026
Q1
$391K Sell
815
-720
-47% -$369K ﹤0.01% 650
2025
Q4
$862K Sell
1,535
-50
-3% -$28.4K 0.01% 431
2025
Q3
$815K Sell
1,585
-62
-4% -$27.1K 0.01% 462
2025
Q2
$517K Buy
1,647
+147
+10% +$44.1K ﹤0.01% 541
2025
Q1
$457K Sell
1,500
-70
-4% -$23.5K ﹤0.01% 550
2024
Q4
$522K Buy
1,570
+160
+11% +$54.3K 0.01% 523
2024
Q3
$471K Buy
1,410
+100
+8% +$38K ﹤0.01% 530
2024
Q2
$540K Sell
1,310
-40
-3% -$15.8K 0.01% 480
2024
Q1
$546K Hold
1,350
0.01% 482
2023
Q4
$414K Buy
1,350
+52
+4% +$14K ﹤0.01% 524
2023
Q3
$314K Buy
1,298
+283
+28% +$72.4K ﹤0.01% 554
2023
Q2
$244K Buy
+1,015
New +$211K ﹤0.01% 595
2023
Q1
Sell
-1,315
Closed -$279K 679
2022
Q4
$279K Buy
+1,315
New +$263K ﹤0.01% 565
2022
Q1
Sell
-1,065
Closed -$232K 687
2021
Q4
$232K Sell
1,065
-246
-19% -$51.5K ﹤0.01% 615
2021
Q3
$248K Hold
1,311
﹤0.01% 577
2021
Q2
$232K Hold
1,311
﹤0.01% 581
2021
Q1
$215K Buy
+1,311
New +$201K ﹤0.01% 575

Other funds holding MEDP

Johnson Investment Counsel's MEDP Position: Q2 2026 in Review

Johnson Investment Counsel held its Medpace (MEDP) position steady in Q2 2026 at 815 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Johnson Investment Counsel first reported a position in MEDP in Q1 2021 and has held it in 18 quarters since. The position peaked at $862K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Johnson Investment Counsel held 815 shares of Medpace worth $432K as of Q2 2026.
  • Johnson Investment Counsel left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #653 holding.
  • Johnson Investment Counsel first reported a position in Medpace in Q1 2021 and has held it in 18 quarters since.
  • Johnson Investment Counsel's Medpace position peaked at $862K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.